Max Hellrung

Entering Year


Research: Max is studying macrophages in the tumor microenvironment of triple negative breast cancer (TNBC) and how macrophages can act as a method of targeting TNBC. Max is researching LYVE1+ macrophages, a subset of tumor-promoting macrophages that are also important for removing apoptotic cells in TNBC tumors through efferocytosis. Max is interested in how this efferocytosis impacts the gene expression of LYVE1+ macrophages and how that might be connected to their tumor-promoting phenotype. 

Max Hellrung